ConductScience.org, home

Paper6286802

Interferon induction by 5-halo-6-phenyl pyrimidinones.

Stringfellow DA and 2 others. J Interferon Res, 1980. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Interferon induction by 5-halo-6-phenyl pyrimidinones. Papers, record 6286802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6286802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interferon induction by 5-halo-6-phenyl pyrimidinones.
PubMed
Journal
J Interferon Res
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2019-12-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stringfellow DAD A
2Vanderberg HCH C
3Weed SDS D

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon InducersMajor topic
PyrimidinonesMajor topic
Animals
Antiviral Agents
Cats
Cattle
Cells, Cultured
Cytosine
Encephalomyocarditis virus
Female
Fibroblasts
Humans
Hydrocarbons, Halogenated
L Cells
Mice
Mice, Inbred ICR
Pyrimidines
Semliki forest virus
Vesicular stomatitis Indiana virus

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
32203790Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes.Eur J Med Chem2020https://conductscience.org/library/papers/32203790PubMed
22257721Microarray analysis on germfree mice elucidates the primary target of a traditional Japanese medicine juzentaihoto: acceleration of IFN-α response via affecting the ISGF3-IRF7 signaling cascade.BMC Genomics2012https://conductscience.org/library/papers/22257721PubMed
11173644Molecular Events as Targets of Anticancer Drug Therapy.Pathol Oncol Res1997https://conductscience.org/library/papers/11173644PubMed
6336272Studies on the antitumor activities of pyrimidinone-interferon inducers. Part 2. Potentiation of antitumor resistance mechanisms.Clin Exp Metastasis1983https://conductscience.org/library/papers/6336272PubMed
6166253Chemotherapy of viral infections.Arch Dermatol Res1981https://conductscience.org/library/papers/6166253PubMed
3872188Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes.Clin Exp Immunol1985https://conductscience.org/library/papers/3872188PubMed
3741769Site-specific antitumour effects of 2 pyrimidinone compounds in rats.Br J Cancer1986https://conductscience.org/library/papers/3741769PubMed
3000290Effect of pyrimidinone treatment on lethal and immunosuppressive murine cytomegalovirus infection.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3000290PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6286802

GET https://conductscience.org/api/papers/v1/6286802/authors